| Gene symbol | KLRK1 | Synonyms | CD314, D12S2489E, KLR, NKG2-D, NKG2D | Type of gene | protein-coding |
| Chromosome | 12 | Map location | 12p13.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | killer cell lectin like receptor K1 | ||||
| GTO ID | GTC3035 |
| Trial ID | NCT05382377 |
| Disease | Ovarian Cancer | Cholangiocarcinoma Cancer | Colorectal Cancer |
| Altered gene | NKG2D |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | NKG2D CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors |
| Year | 2022 |
| Country | China |
| Company sponsor | jianming xu |
| Other ID(s) | KD-025-XJM |
| Cohort 1 | |||||||||||
|
|||||||||||